reglab/housing_qa huggingface dataset:
NE Code § 71-2417 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2417 - Controlled substance; exemption.

71-2417.  Controlled substance; exemption.Any emergency box containing a controlled substance listed in section 28-405 and maintained at a long-term care facility shall be exempt from subsection (3) of section 28-414.03.Source   Laws 1994, LB 1210, § 189;   Laws 1995, LB 406, § 38;  Laws 1999, LB 594, § 59;  Laws 2001, LB 398, § 72;  Laws 2009, LB195, § 74;  Laws 2014, LB811, § 27.
NE Code § 71-2418 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2418 - Legislative findings.

71-2418.  Legislative findings.(1) The Legislature finds that many controlled substances have useful and legitimate medical and scientific purposes and are necessary to maintain the health and general welfare of the people of Nebraska. Principles of quality medical practice dictate that the people of Nebraska have access to appropriate and effective pain relief.(2) The Legislature finds that the appropriate application of up-to-date knowledge and treatment modalities can serve to improve the quality of life for those patients who suffer from pain. The Legislature therefor encourages physicians to view effective pain management as a part of quality medical practice for all patients with pain, acute or chronic, including those patients who experience pain as a result of terminal illness.(3) The Legislature finds that a physician should be able to prescribe, dispense, or administer a controlled substance in excess of the recommended dosage for the treatment of pain so long as such dosage is not administered for the purpose of causing, or the purpose of assisting in causing, death for any reason and so long as it conforms to policies and guidelines for the treatment of pain adopted by the Board of Medicine and Surgery.(4) The Legislature finds that a health care facility, hospice, or third-party payor should not forbid or restrict the use of controlled substances appropriately administered for the treatment of pain.Source  Laws 1999, LB 226, § 1;  Laws 2007, LB463, § 1196.
NE Code § 71-2419 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2419 - Physician, nurse, or pharmacist; disciplinary action or criminal prosecution; limitation.

71-2419.  Physician, nurse, or pharmacist; disciplinary action or criminal prosecution; limitation.A physician licensed under the Medicine and Surgery Practice Act who prescribes, dispenses, or administers or a nurse licensed under the Nurse Practice Act or pharmacist licensed under the Pharmacy Practice Act who administers or dispenses a controlled substance in excess of the recommended dosage for the treatment of pain shall not be subject to discipline under the Uniform Credentialing Act or criminal prosecution under the Uniform Controlled Substances Act when: (1) In the judgment of the physician, appropriate pain management warrants such dosage; (2) the controlled substance is not administered for the purpose of causing, or the purpose of assisting in causing, death for any reason; and (3) the administration of the controlled substance conforms to policies and guidelines for the treatment of pain adopted by the Board of Medicine and Surgery.Source  Laws 1999, LB 226, § 2;  Laws 2001, LB 398, § 73;  Laws 2007, LB463, § 1197. Cross References   Medicine and Surgery Practice Act, see section 38-2001.  Nurse Practice Act, see section 38-2201.  Pharmacy Practice Act, see section 38-2801.  Uniform Controlled Substances Act, see section 28-401.01.  Uniform Credentialing Act, see section 38-101.
NE Code § 71-2420 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2420 - Board of Medicine and Surgery; duties.

71-2420.  Board of Medicine and Surgery; duties.The Board of Medicine and Surgery shall adopt policies and guidelines for the treatment of pain to ensure that physicians who are engaged in the appropriate treatment of pain are not subject to disciplinary action, and the board shall consider policies and guidelines developed by national organizations with expertise in pain management for this purpose.Source  Laws 1999, LB 226, § 3;  Laws 2007, LB463, § 1198.
NE Code § 71-2421 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2421 - Transferred to section 38-28,107.

71-2421.  Transferred to section 38-28,107.
NE Code § 71-2422 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2422 - Cancer Drug Repository Program Act; act, how cited.

71-2422.  Cancer Drug Repository Program Act; act, how cited.Sections 71-2422 to 71-2430 shall be known and may be cited as the Cancer Drug Repository Program Act.Source  Laws 2003, LB 756, § 1;  Laws 2005, LB 331, § 1.
NE Code § 71-2423 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2423 - Terms, defined.

71-2423.  Terms, defined.For purposes of the Cancer Drug Repository Program Act:(1) Cancer drug means a prescription drug used to treat (a) cancer or its side effects or (b) the side effects of a prescription drug used to treat cancer or its side effects;(2) Department means the Department of Health and Human Services;(3) Health care facility has the definition found in section 71-413;(4) Health clinic has the definition found in section 71-416;(5) Hospital has the definition found in section 71-419;(6) Participant means a physician's office, pharmacy, hospital, or health clinic that has elected to voluntarily participate in the program and that accepts donated cancer drugs under the rules and regulations adopted and promulgated by the department for the program;(7) Pharmacy has the definition found in section 71-425;(8) Physician's office means the office of a person licensed to practice medicine and surgery or osteopathic medicine and surgery;(9) Prescribing practitioner means a health care practitioner licensed under the Uniform Credentialing Act who is authorized to prescribe cancer drugs;(10) Prescription drug has the definition found in section 38-2841; and(11) Program means the cancer drug repository program established pursuant to section 71-2424.Source  Laws 2003, LB 756, § 2;  Laws 2005, LB 331, § 2;  Laws 2007, LB296, § 541;  Laws 2007, LB463, § 1200. Cross References  Uniform Credentialing Act, see section 38-101.
NE Code § 71-2424 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2424 - Cancer drug repository program; established.

71-2424.  Cancer drug repository program; established.The department shall establish a cancer drug repository program for accepting donated cancer drugs and dispensing such drugs to Nebraska residents. Participation in the program shall be voluntary.Source Laws 2003, LB 756, § 3.
NE Code § 71-2425 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2425 - Cancer drug donation.

71-2425.  Cancer drug donation.Any person or entity, including, but not limited to, a cancer drug manufacturer or health care facility, may donate cancer drugs to the program. Cancer drugs may be donated to a participant.Source  Laws 2003, LB 756, § 4;  Laws 2005, LB 331, § 3.
NE Code § 71-2426 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2426 - Cancer drug; accepted or dispensed; conditions.

71-2426.  Cancer drug; accepted or dispensed; conditions.(1) A cancer drug shall only be accepted or dispensed under the program if such drug is in its original, unopened, sealed, and tamper-evident packaging. A cancer drug packaged in single unit doses may be accepted and dispensed if the outside packaging is opened but the single-unit-dose packaging is unopened. There shall be no limitation on the number of doses that can be donated to the program as long as the donated drugs meet the requirements of this section. An injectable cancer drug may be accepted if it does not have temperature requirements other than controlled room temperature.(2) A cancer drug shall not be accepted or dispensed under the program if (a) such drug bears an expiration date prior to the date of donation, (b) such drug is adulterated or misbranded as defined in section 71-2461 or 71-2470, (c) such drug has expired while in the repository, or (d) such drug has restricted distribution by the federal Food and Drug Administration.(3) Subject to limitations provided in this section, unused cancer drugs dispensed under the medical assistance program established pursuant to the Medical Assistance Act may be accepted and dispensed under the program.Source  Laws 2003, LB 756, § 5;  Laws 2005, LB 331, § 4;  Laws 2006, LB 1116, § 1;  Laws 2006, LB 1248, § 77;  Laws 2015, LB37, § 74.  Cross References  Medical Assistance Act, see section 68-901.
NE Code § 71-2427 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2427 - Participant; duties; fee authorized.

71-2427.  Participant; duties; fee authorized.(1) A participant shall comply with all applicable provisions of state and federal law relating to the storage, distribution, and dispensing of donated cancer drugs and shall inspect all such drugs prior to dispensing to determine if they are adulterated or misbranded as defined in section 71-2461 or 71-2470. Such drugs shall only be dispensed pursuant to a prescription issued by a prescribing practitioner. Such drugs may be distributed to another participant for dispensing.(2) A participant may charge a handling fee for distributing or dispensing cancer drugs under the program. Such fee shall be established in rules and regulations adopted and promulgated by the department. Cancer drugs donated under the program shall not be resold.Source  Laws 2003, LB 756, § 6;  Laws 2005, LB 331, § 5;  Laws 2015, LB37, § 75.
NE Code § 71-2428 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2428 - Immunity.

71-2428.  Immunity.(1) Any person or entity, including a cancer drug manufacturer, which exercises reasonable care in donating, accepting, distributing, or dispensing cancer drugs under the Cancer Drug Repository Program Act or rules and regulations adopted and promulgated under the act shall be immune from civil or criminal liability or professional disciplinary action of any kind for any injury, death, or loss to person or property relating to such activities.(2) Notwithstanding subsection (1) of this section, the donation of a cancer drug by a cancer drug manufacturer does not absolve the manufacturer of any criminal or civil liability that would have existed but for the donation, nor shall such donation increase the liability of such cancer drug manufacturer that would have existed but for the donation.Source Laws 2003, LB 756, § 7.
NE Code § 71-2429 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2429 - Rules and regulations.

71-2429.  Rules and regulations.The department, upon the recommendation of the Board of Pharmacy, shall adopt and promulgate rules and regulations to carry out the Cancer Drug Repository Program Act. Such rules and regulations shall include, but not be limited to:(1) Eligibility criteria and other standards and procedures for participants that accept and distribute or dispense donated cancer drugs;(2) Necessary forms for administration of the program, including, but not limited to, forms for use by persons or entities that donate, accept, distribute, or dispense cancer drugs under the program. The forms shall include the name of the person to whom the drug was originally prescribed;(3) The maximum handling fee that may be charged by participants that accept and distribute or dispense donated cancer drugs;(4)(a) Categories of cancer drugs that the program will accept for dispensing and (b) categories of cancer drugs that the program will not accept for dispensing and the reason that such drugs will not be accepted; and(5) Maintenance and distribution of the participant registry established in section 71-2430.Source  Laws 2003, LB 756, § 8;  Laws 2005, LB 331, § 6;  Laws 2006, LB 1116, § 2.
NE Code § 71-2430 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2430 - Participant registry.

71-2430.  Participant registry.The department shall establish and maintain a participant registry for the program. The participant registry shall include the participant's name, address, and telephone number and shall identify whether the participant is a physician's office, a pharmacy, a hospital, or a health clinic. The department shall make the participant registry available to any person or entity wishing to donate cancer drugs to the program.Source Laws 2005, LB 331, § 7.
NE Code § 71-2431 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2431 - Community health center; relabeling and redispensing prescription drugs; requirements.

71-2431.  Community health center; relabeling and redispensing prescription drugs; requirements.(1) Prescription drugs or devices which have been delivered to a community health center for dispensing to a patient of such health center pursuant to a valid prescription, but which are not dispensed or administered to such patient, may be delivered to a pharmacist or pharmacy under contract with the community health center for relabeling and redispensing to another patient of such health center pursuant to a valid prescription if:(a) The decision to accept delivery of the drug or device for relabeling and redispensing rests solely with the contracting pharmacist or pharmacy;(b) The drug or device has been in the control of the community health center at all times;(c) The drug or device is in the original and unopened labeled container with a tamper-evident seal intact. Such container shall bear the expiration date or calculated expiration date and lot number; and(d) The relabeling and redispensing is not otherwise prohibited by law.(2) For purposes of this section:(a) Administer has the definition found in section 38-2806;(b) Calculated expiration date has the definition found in section 38-2884;(c) Community health center means a community health center established pursuant to the Health Centers Consolidation Act of 1996, 42 U.S.C. 201 et seq., as such act existed on May 7, 2005;(d) Deliver or delivery has the definition found in section 38-2813;(e) Dispense or dispensing has the definition found in section 38-2817;(f) Prescription has the definition found in section 38-2840; and(g) Prescription drug or device has the definition found in section 38-2841.(3) The Department of Health and Human Services, in consultation with the Board of Pharmacy, may adopt and promulgate rules and regulations to carry out this section.Source  Laws 2005, LB 382, § 14;  Laws 2007, LB296, § 542;  Laws 2007, LB463, § 1201.
NE Code § 71-2432 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2432 - Terms, defined.

71-2432.  Terms, defined.For purposes of sections 71-2432 to 71-2435:(1) Clandestine drug lab means any area where glassware, heating devices, or other equipment or precursors, solvents, or related articles or reagents are used to unlawfully manufacture methamphetamine;(2) Contaminated property means an enclosed area of any property or portion thereof intended for human habitation or use which has been contaminated by chemicals, chemical residue, methamphetamine, methamphetamine residue, or other substances from a clandestine drug lab;(3) Department means the Department of Health and Human Services;(4) Law enforcement agency has the meaning found in section 81-1401;(5) Local public health department has the meaning found in section 71-1626;(6) Methamphetamine means methamphetamine, its salts, optical isomers, and salts of its isomers; and(7) Rehabilitate or rehabilitation means all actions necessary to ensure that contaminated property is safe for human habitation or use.Source  Laws 2006, LB 915, § 1;  Laws 2007, LB296, § 543.
NE Code § 71-2433 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2433 - Property owner; law enforcement agency; Nebraska State Patrol; duties.

71-2433.  Property owner; law enforcement agency; Nebraska State Patrol; duties.A property owner with knowledge of a clandestine drug lab on his or her property shall report such knowledge and location as soon as practicable to the local law enforcement agency or to the Nebraska State Patrol. A law enforcement agency that discovers a clandestine drug lab in the State of Nebraska shall report the location of such lab to the Nebraska State Patrol within thirty days after making such discovery. Such report shall include the date of discovery of such lab, the county where the property containing such lab is located, and a legal description of the property or other description or address of such property sufficient to clearly establish its location. As soon as practicable after such discovery, the appropriate law enforcement agency shall provide the Nebraska State Patrol with a complete list of the chemicals, including methamphetamine, its precursors, solvents, and related reagents, found at or removed from the location of such lab. Upon receipt, the Nebraska State Patrol shall promptly forward a copy of such report and list to the department, the Department of Environment and Energy, the municipality or county where the lab is located, the director of the local public health department serving such municipality or county, and the property owner or owners.Source  Laws 2006, LB 915, § 2;  Laws 2019, LB302, § 88.
NE Code § 71-2434 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2434 - Local public health department; powers and duties; fees; release of property for human habitation; civil penalty.

71-2434.  Local public health department; powers and duties; fees; release of property for human habitation; civil penalty.(1) The local public health department serving the municipality or county where a clandestine drug lab has been discovered shall monitor the rehabilitation of any contaminated property at such location in accordance with standards and procedures established or approved by the department. The department shall adopt and promulgate rules and regulations to establish such standards and procedures no later than July 15, 2007. Such procedures shall include deadlines for completion of the various stages of rehabilitation and proper disposal of the contaminated property.(2) A local public health department may charge and collect fees from the owner or owners of contaminated property to cover the costs directly associated with monitoring the rehabilitation of such property under this section as provided in rules and regulations of the department. A local public health department may contract with other local public health departments or other appropriate entities to assist in the monitoring of such rehabilitation. Upon the completion of such rehabilitation, the local public health department shall release the property for human habitation and commercial or other use in a timely manner.(3) The owner or owners of contaminated property shall not permit the human habitation or use of such property until the rehabilitation of such property has been completed and the property has been released for such habitation or use under this section. An owner who knowingly violates this subsection may be subject to a civil penalty not to exceed one thousand dollars. The department shall enforce this subsection.Source Laws 2006, LB 915, § 3.
NE Code § 71-2435 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2435 - Leased property; termination of lease; notice.

71-2435.  Leased property; termination of lease; notice.Notwithstanding any other provision of law, if leased property contains a clandestine drug lab, an owner may terminate the lease agreement upon three days' written notice for the purpose of rehabilitating the contaminated property in accordance with the rules and regulations adopted and promulgated pursuant to section 71-2434.Source Laws 2006, LB 915, § 4.
NE Code § 71-2436 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2436 - Immunosuppressant Drug Repository Program Act; act, how cited.

71-2436.  Immunosuppressant Drug Repository Program Act; act, how cited.Sections 71-2436 to 71-2443 shall be known and may be cited as the Immunosuppressant Drug Repository Program Act.Source Laws 2006, LB 994, § 42.
NE Code § 71-2437 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2437 - Terms, defined.

71-2437.  Terms, defined.For purposes of the Immunosuppressant Drug Repository Program Act:(1) Department means the Department of Health and Human Services;(2) Immunosuppressant drug means anti-rejection drugs that are used to reduce the body's immune system response to foreign material and inhibit a transplant recipient's immune system from rejecting a transplanted organ. Immunosuppressant drugs are available only as prescription drugs and come in tablet, capsule, and liquid forms. The recommended dosage depends on the type and form of immunosuppressant drug and the purpose for which it is being used. Immunosuppressant drug does not include drugs prescribed for inpatient use;(3) Participant means a transplant center that has elected to voluntarily participate in the program, that has submitted written notification to the department of its intent to participate in the program, and that accepts donated immunosuppressant drugs under the rules and regulations adopted and promulgated by the department for the program;(4) Prescribing practitioner means a health care practitioner licensed under the Uniform Credentialing Act who is authorized to prescribe immunosuppressant drugs;(5) Prescription drug has the definition found in section 38-2841;(6) Program means the immunosuppressant drug repository program established pursuant to section 71-2438;(7) Transplant center means a hospital that operates an organ transplant program, including qualifying patients for transplant, registering patients on the national waiting list, performing transplant surgery, and providing care before and after transplant; and(8) Transplant program means the organ-specific facility within a transplant center. A transplant center may have transplant programs for the transplantation of hearts, lungs, livers, kidneys, pancreata, or intestines.Source  Laws 2006, LB 994, § 43;  Laws 2007, LB296, § 544;  Laws 2007, LB463, § 1202. Cross References  Uniform Credentialing Act, see section 38-101.
NE Code § 71-2438 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2438 - Immunosuppressant drug repository program; established.

71-2438.  Immunosuppressant drug repository program; established.The department shall establish an immunosuppressant drug repository program for accepting donated immunosuppressant drugs and dispensing such drugs. Participation in the program shall be voluntary.Source Laws 2006, LB 994, § 44.
NE Code § 71-2439 (2021)
2021 Nebraska Revised Statutes|Chapter 71 - Public Health and Welfare|71-2439 - Immunosuppressant drug donation.

71-2439.  Immunosuppressant drug donation.Any person or entity, including, but not limited to, an immunosuppressant drug manufacturer or transplant center, may donate immunosuppressant drugs to a participant or return previously prescribed immunosuppressant drugs to the transplant center where they were originally prescribed.Source Laws 2006, LB 994, § 45.